Research Article| Volume 68, ISSUE 2, P131-140, February 2014

Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran – A prospective multicenter point prevalence study

Published:November 21, 2013DOI:



      We aimed to compare the features of intensive care units (ICUs), their antimicrobial resistance patterns, infection control policies, and distribution of infectious diseases from central Europe to Mid-West Asia.


      A cross-sectional point prevalence study was performed in 88 ICUs from 12 countries. Characteristics of ICUs, patient and antibiotic therapy data were collected with a standard form by infectious diseases specialists.


      Out of 749, 305 patients at least with one infectious disease were assessed and 254 patients were reported to have coexistent medical problems. When primary infectious diseases diagnoses of the patients were evaluated, 69 had community-acquired, 61 had healthcare-associated, and 176 had hospital-acquired infections. Pneumonia was the most frequent ICU infection seen in half of the patients. Distribution of frequent pathogens was as follows: Enteric Gram-negatives (n = 62, 28.8%), Acinetobacter spp. (n = 47, 21.9%), Pseudomonas aeruginosa (n = 29, 13.5%). Multidrug resistance profiles of the infecting microorganisms seem to have a uniform pattern throughout Southern Europe and Turkey. On the other hand, active and device-associated infection surveillance was performed in Turkey more than Iran and Southeastern Europe (p < 0.05). However, designing antibiotic treatment according to culture results was highest in Southeastern Europe (p < 0.05). The most frequently used antibiotics were carbapenems (n = 92, 30.2%), followed by anti-gram positive agents (vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline; n = 79, 25.9%), beta-lactam/beta lactamase inhibitors (n = 78, 25.6%), and extended-spectrum cephalosporins (n = 73, 23.9%).


      ICU features appears to have similar characteristics from the infectious diseases perspective, although variability seems to exist in this large geographical area.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Erdem H.
        • Akova M.
        Leading infectious diseases problems in Turkey.
        Clin Microbiol Infect. 2012; 18: 1056-1067
        • Shibl A.
        • Senok A.
        • Memish Z.
        Infectious diseases in the Arabian Peninsula and Egypt.
        Clin Microbiol Infect. 2012; 18: 1068-1080
        • Askarian M.
        • Mansour Ghanaie R.
        • Karimi A.
        • Habibzadeh F.
        Infectious diseases in Iran: a bird's eye view.
        Clin Microbiol Infect. 2012; 18: 1081-1088
        • Bonten M.J.
        Healthcare epidemiology: ventilator-associated pneumonia: preventing the inevitable.
        Clin Infect Dis. 2011; 52: 115-121
        • Allegranzi B.
        • Bagheri Nejad S.
        • Combescure C.
        • Graafmans W.
        • Attar H.
        • Donaldson L.
        • et al.
        Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis.
        Lancet. 2011; 377: 228-241
        • Erdem H.
        • Dizbay M.
        • Karabey S.
        • Kaya S.
        • Demirdal T.
        • Koksal I.
        • et al.
        Withdrawal of Staphylococcus aureus from intensive care units in Turkey.
        Am J Infect Control. 2013; 41: 1053-1058
        • Levy M.M.
        • Fink M.P.
        • Marshall J.C.
        • Abraham E.
        • Angus D.
        • Cook D.
        • et al.
        2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference.
        Crit Care Med. 2003; 31: 1250-1256
        • Magiorakos A.P.
        • Srinivasan A.
        • Carey R.B.
        • Carmeli Y.
        • Falagas M.E.
        • Giske C.G.
        • et al.
        Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
        Clin Microbiol Infect. 2012; 18: 268-281
        • Freeman G.H.
        • Halton J.H.
        Note on exact treatment of contingency, goodness of fit and other problems of significance.
        Biometrika. 1951; 38: 141-149
        • Firth P.
        • Ttendo S.
        Intensive care in low-income countries – a critical need.
        N Engl J Med. 2012; 367: 1974-1976
        • Erdem H.
        • Kurtaran B.
        • Arun O.
        • Yilmaz H.
        • Celebi G.
        • Ozkaya H.D.
        • et al.
        The place and the efficacy of infectious disease consultations in the hospitals.
        Infect Dis Clin Pract. 2012; 20: 131-136
        • McGahan M.
        • Kucharski G.
        • Coyer F.
        Nurse staffing levels and the incidence of mortality and morbidity in the adult intensive care unit: a literature review.
        Aust Crit Care. 2012; 25: 64-77
        • Vincent J.L.
        • Bihari D.J.
        • Suter P.M.
        • Bruining H.A.
        • White J.
        • Nicolas-Chanoin M.H.
        • et al.
        The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
        J Am Med Assoc. 1995; 274: 639-644
        • Vincent J.L.
        • Rello J.
        • Marshall J.
        • Silva E.
        • Anzueto A.
        • Martin C.D.
        • et al.
        International study of the prevalence and outcomes of infection in intensive care units.
        J Am Med Assoc. 2009; 302: 2323-2329
        • Pilato F.
        • Profice P.
        • Dileone M.
        • Ranieri F.
        • Capone F.
        • Minicuci G.
        • et al.
        Stroke in critically ill patients.
        Minerva Anestesiol. 2009; 75: 245-250
        • Rubenfeld G.D.
        Interventions to improve long-term outcomes after critical illness.
        Curr Opin Crit Care. 2007; 13: 476-481
        • Vardakas K.Z.
        • Rafailidis P.I.
        • Konstantelias A.A.
        • Falagas M.E.
        Predictors of mortality in patients with infections due to multidrug resistant Gram negative bacteria: the study, the patient, the bug or the drug?.
        J Infect. 2013; 66: 401-414
        • Rosenthal V.D.
        • Maki D.G.
        • Salomao R.
        • Moreno C.A.
        • Mehta Y.
        • Higuera F.
        • et al.
        Device-associated nosocomial infections in 55 intensive care units of 8 developing countries.
        Ann Intern Med. 2006; 145: 582-591
        • Mehta Y.
        • Jaggi N.
        • Rosenthal V.D.
        • Rodrigues C.
        • Todi S.K.
        • Saini N.
        • et al.
        Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 21 adult intensive-care units from 10 cities in India: findings of the International Nosocomial Infection Control Consortium (INICC).
        Epidemiol Infect. 2013; : 1-9
        • Bukhari S.Z.
        • Hussain W.M.
        • Banjar A.A.
        • Fatani M.I.
        • Karima T.M.
        • Ashshi A.M.
        Application of ventilator care bundle and its impact on ventilator associated pneumonia incidence rate in the adult intensive care unit.
        Saudi Med J. 2012; 33: 278-283
        • Schwaber M.J.
        • Carmeli Y.
        The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy.
        Crit Care. 2009; 13: 106
        • Giske C.G.
        • Monnet D.L.
        • Cars O.
        • Carmeli Y.
        Clinical and economic impact of common multidrug-resistant gram-negative bacilli.
        Antimicrobial Agents Chemother. 2008; 52: 813-821
        • Inan A.
        • Ozgultekin A.
        • Akcay S.S.
        • Engin D.O.
        • Turan G.
        • Ceran N.
        • et al.
        Alterations in bacterial spectrum and increasing resistance rates in isolated microorganisms from device-associated infections in an intensive care unit of a teaching hospital in Istanbul (2004–2010).
        Jpn J Infect Dis. 2012; 65: 146-151
        • Pourakbari B.
        • Sadr A.
        • Ashtiani M.T.
        • Mamishi S.
        • Dehghani M.
        • Mahmoudi S.
        • et al.
        Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran.
        J Infect Dev Ctries. 2012; 6: 120-125